Key Points
- Stock futures are up as investors eye earnings and positive news. OPEC+ will pause oil output hikes in the first quarter of 2026.
- China suspended new rare earth curbs as part of a U.S. trade truce.
- Berkshire Hathaway’s cash pile reached a new record high.
- Kimberly-Clark is buying the maker of Tylenol, Kenvue, for over $40 billion.
Stock futures are pointing to a higher start for the week, as investors look forward to another round of earnings reports and digest a batch of positive news. Key developments include an OPEC+ agreement to pause oil output hikes, China’s decision to suspend new rare earth curbs, a major consumer goods merger, and a record cash pile for Berkshire Hathaway.
Early Monday, futures for the Dow Jones Industrial Average were up 0.09%, while S&P 500 futures climbed 0.26% and the tech-heavy Nasdaq rose 0.48%. This comes after all three major U.S. stock indexes finished October on a strong note. Investors are also preparing for a busy week of earnings from major technology and pharmaceutical companies, with an update from AI favorite Palantir due after today’s closing bell.
Adding to the market’s mood, the Organization of Petroleum Exporting Countries and its allies (OPEC+) agreed on Sunday to pause their oil output hikes in the first quarter of 2026, following a final planned increase in December. The group had been boosting output targets since April, but began slowing in October due to concerns about a supply glut.
A significant boost came from the U.S.-China trade front. Over the weekend, the White House announced that China agreed to suspend new rare-earth export restrictions and to end investigations into American semiconductor companies as part of the trade truce reached by President Donald Trump and President Xi Jinping. China also said it would consider easing export restrictions on Nexperia chips. Shares of Nvidia, AMD, and other chipmakers were higher in premarket trading.
In company news, Warren Buffett’s Berkshire Hathaway reported over the weekend that its cash pile has climbed to a new record high. This has led to speculation that Buffett might be concerned about an overheating market, is waiting for better investment opportunities, or is leaving major decisions to his successor as he prepares to step down as CEO at the end of the year.
In the world of mergers, Kimberly-Clark, the company behind Huggies diapers, announced it will buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion. Kenvue has been facing a leadership shakeup and growing legal issues. In response to the news, Kenvue’s shares soared by more than 20% in premarket trading, while Kimberly-Clark’s shares fell nearly 15%.
